Biomedical Technology Assessment: The 3Q Method
Evaluating biomedical technology poses a significant challenge in light of the complexity and rate of introduction in today's healthcare delivery system. Successful evaluation requires an integration of clinical medicine, science, finance, and market analysis. Little guidance, however, exists for those who must conduct comprehensive technology evaluations. The 3Q Method meets these present day needs. The 3Q Method is organized around 3 key questions dealing with 1) clinical and scientific basis, 2) financial fit and 3) strategic and expertise fit. Both healthcare providers (e.g., hospitals) and medical industry providers can use the Method to evaluate medical devices, information systems and work processes from their own perspectives. The book describes the 3Q Method in detail and provides additional suggestions for optimal presentation and report preparation. Table of Contents: Introduction / Question #1: Is It Real? / Question #2: Can We Win? / Question #3: Is It Worth It? / 3Q Case Study Example -- Pershing Medical Company / Appendix A: Health Care Technology Assessment Sample Class Syllabus / Appendix B: How do Hospitals and Clinicians Get Paid? / Appendix C: Technology Assessment PowerPoint Report Guidelines / Appendix D: Class Report Scenario Example / Appendix E: Four-Blocker Slide Templates for 3Q Reports
What people are saying - Write a review
We haven't found any reviews in the usual places.
Is It Real?
Can We Win?
Is It Worth It?
3Q Case Study Example Pershing Medical Company
Health Care Technology Assessment Sample Class Syllabus
How Do Hospitals and Clinicians Get Paid?
Technology Assessment PowerPoint Report Guidelines
Class Report Scenario Example
FourBlocker Slide Templates for 3Q Reports
Other editions - View all
3Qanalysis 3QMethod 3Qreport Accumulated units algorithm Altman plot arrhythmia beneﬁcial beneﬁt Biomedical Engineers blood pressure calculated cardiac output catheter CHF clinic Clinical limits clinical range clinical studies clinical testing clinically acceptable clinicians company’s competitive competitors data points deﬁned deﬁnition difﬁcult efﬁcacious estimates evaluation example existing products expense ﬁeld ﬁgures ﬁnal ﬁnancial ﬁndings ﬁrst ﬁve ﬁve-year projection ﬂow Gold Standard Comparison healthcare hospital hospital’s important incremental l/min leadership image limits of agreement MAARIE Market growth market share medical technology method NICO product NICO technology Nobis outcome variables oximeter p-value patient monitoring PMC’s potential pulse oximetry question randomized clinical trial reduction reimbursement requirements revenue sample scientiﬁc screening system slide speciﬁc staff statistically signiﬁcant strategic ﬁt strategic plan sufﬁcient Table TAKEAWAY TAKEAWAY target technology assessment therapy today’s Truth Table two-arm trial usually vendor ventilator workﬂow